The fatty liver index: A simple and accurate predictor of hepatic steatosis in the general population

BMC Gastroenterology

Volumn 6, Issue , 2006, Pages

  Bedogni, Giorgio ^a,c   Bellentani, Stefano ^b   Miglioli, Lucia ^b   Masutti, Flora ^a,c   Passalacqua, Marilena ^b   Castiglione, Anna ^a,c   Tiribelli, Claudio ^a,c  

^a Centro Studi Fegato   (Italy)

^b AUSL Modena   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ALGORITHM; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ECHOGRAPHY; FATTY LIVER; FATTY LIVER INDEX; FEMALE; GENDER BIAS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; PATIENT COUNSELING; PATIENT SELECTION; PREDICTION; SENSITIVITY AND SPECIFICITY; SKINFOLD THICKNESS; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; ALGORITHMS; BODY MASS INDEX; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INTRA-ABDOMINAL FAT; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TRIGLYCERIDES;

EID: 33751246499     PISSN: 1471230X     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-6-33     Document Type: Article

References (32)

1. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S: Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005, 42:44-52.
2. Bellentani S, Bedogni G, Miglioli L, Tiribelli C: The epidemiology of fatty liver. Eur J Gastroenterol Hepatol 2004, 16:1087-1093.
3. Bedogni G, Bellentani S: Fatty liver: how frequent is it and why? Ann Hepatol 2004, 3:63-65.
4. Neuschwander-Tetri BA, Caldwell SH: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003, 37:1202-1219.
5. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
6. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, Cristanini G, Tiribelli C: Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000, 132:112-117.
7. Bellentani S, Tiribelli C: The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol 2001, 35:531-537.
8. Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, Li F, Chen SY: Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005, 43:508-514.
9. Bedogni G, Pietrobelli A, Heymsfield SB, Borghi A, Manzieri AM, Morini P, Battistini N, Salvioli G: Is body mass index a measure of adiposity in elderly women? Obes Res 2001, 9:17-20.
10. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Yaffe K: Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005, 330:1360.
11. Twisk JW, Kemper HC, van Mechelen W, Post GB, van Lenthe FJ: Body fatness: longitudinal relationship of body mass index and the sum of skinfolds with other risk factors for coronary heart disease. Int J Obes Relat Metab Disord 1998, 22:915-922.
12. Bugianesi E, McCullough AJ, Marchesini G: Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005, 42:987-1000.
13. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, Cristianini G: Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 1994, 20:1442-1449.
14. Bellentani S, Pozzato G, Saccoccio G, Crovatto M, Crocè LS, Mazzoran L, Masutti F, Cristianini G, Tiribelli C: Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut 1999, 44:874-880.
15. Lohman, Roche, Martorell: Anthropometric standardization reference manual Champaign, IL: Human Kinetics Books; 1988.
16. Durnin JV, Womersley J: Total body fat, calculated from body density, and its relationship to skinfold thickness in 571 people aged 12-72 years. Proc Nutr Soc 1973, 32:45A.
17. Fiori G, Facchini F, Pettener D, Rimondi A, Battistini N, Bedogni G: Relationships between blood pressure, anthropometric characteristics and blood lipids in high- and low-altitude populations from Central Asia. Ann Hum Biol 2000, 27:19-28.
18. Thompson FE, Byers T: Dietary assessment resource manual. J Nutr 1994, 124:2245S-2317S.
19. Willett W: Nutritional epidemiology New York: Oxford University Press; 1998.
20. MacDonald I: Health issues related to alcohol consumption ILSI Press; 1993.
21. Steyerberg EW, Harrell FE, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD: Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001, 54:774-781.
22. Box GEP, Tidwell PW: Transformation of the Independent Variables. Technometrics 1962, 4:531-550.
23. Zhou, Obuchowski, McClish: Statistical methods in diagnostic medicine New York: Wiley; 2002.
24. Hosmer DW, Lemeshow S: Applied logistic regression New York: Wiley; 2000.
25. Farin HM, Abbasi F, Reaven GM: Body mass index and waist circumference correlate to the same degree with insulin-mediated glucose uptake. Metabolism 2005, 54:1323-1328.
26. Reaven GM: The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006, 83:1237-1247.
27. Ratziu V, Massard J, Charlotte F, Messous D, Imbert-Bismut F, Bonyhay L, Tahiri M, Munteanu M, Thabut D, Cadranell JF, Le Bail B, de Ledinghen V, Poynard T, LIDO Study Group, CYTOL study group: Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2006, 6:6.
28. Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D, Capron D, Abella A, Massard J, Ngo Y, Munteanu M, Mercadier A, Manns M, Albrecht J: The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 2005, 4:10.
29. Kushner RF, Blatner DJ: Risk assessment of the overweight and obese patient. J Am Diet Assoc 2005, 105:S53-S62.
30. Bayard M, Holt J, Boroughs E: Nonalcoholic fatty liver disease. Am Fam Physician 2006, 73:1961-1968.
31. Marchesini G, Natale S, Manini R, Agostini F: Review article: the treatment of fatty liver disease associated with the metabolic syndrome. Aliment Pharmacol Ther 2005, 22(Suppl 2):37-39.
32. Comar KM, Sterling RK: Review article: Drug therapy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2006, 23:207-215.